| Application no. and date | 16721605.0 (espacenet) (Federated) (European Patent Register), 20160428 | | Patent/reg. no. and date | DK/EP 3292141, 20200212 | | Publication date | 20180314 | | Priority no. and date | US 201562158079 P, 20150507 | | EP pub. no. and date |
EP 3292141 20180314 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | P42000641DK00E | | Inventor | BEALS, John Michael, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
DICKINSON, Craig Duane, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
BALDWIN, David Bruce, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
DAY, Jonathan Wesley, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
KORYTKO, Andrew Ihor, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
LAZAR, Gregory Alan, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/28 (2006.01) , C07K 14/62 (2006.01) , C12N 15/62 (2006.01) | | Title | FUSIONSPROTEINER | | Int. application no. | US2016029807 | | Int. publication no. | WO2016178905 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
